Tower Research Capital LLC (TRC)
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in FULC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$27,428
-$22,940 QoQ
Shares Held
7,494
+14.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#119
of 155 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. FULC ranks #198 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in FULC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,428 | 7,494 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $50,368 | 6,567 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,367 | 1,624 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,572 | 1,910 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $43,873 | 6,377 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $23,996 | 8,332 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,682 | 3,975 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $100,387 | 28,120 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $101,208 | 16,324 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $92,993 | 9,851 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,691 | 3,658 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,296 | 5,247 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $36,365 | 11,020 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,872 | 5,920 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $13,278 | 1,824 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $17,094 | 2,113 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $28,924 | 5,903 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $15,703 | 664 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $64,161 | 3,627 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $15,064 | 534 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,323 | 1,653 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,015 | 1,020 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $60,880 | 5,199 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $107,491 | 13,555 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $45,194 | 2,471 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||